North American Neurological Disorder Drugs Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026
The North American neurological disorder drug industry is growing significantly over the forecast period (2020-2026) owing to the rising prevalence of neurological disorders, rising geriatric population, rapid R&D activities by the players in the region. For instance, in May 2019, Allergan Plc announced to share approximately 29 presentations at the 71st Annual American Academy of Neurology (AAN) Meeting regarding neurological disorders and their treatment options.
Further, in December
2019, Ubrelvy was approved by the US FDA. Ubrelvy is a novel drug manufactured
by Allergan Plc for the treatment of neurological disorders especially
migraine.
To
Request a Sample of our Report on North
American Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/north-american-neurological-disorder-drugs-market
Besides, some other
players that support the growth of the North American neurological disorder
drugs market. Players such as Eli Lilly and Co., Merck & Co. Inc., and
Allergan Plc., among others are significantly contributing to the market
growth. These players are continuously contributing to the growth of the market
by adopting several growth strategies in order to curb a large customer base as
well as thrive in such a competitive market.
Market Coverage
·
Market number available for – 2019-2026
·
Base year- 2019
·
Forecast period- 2020-2026
·
Segment Covered- By Disorder Type
·
Region Covered- North America
·
Competitive Landscape- Eli Lilly and Co., Merck
& Co. Inc., Allergan Plc., AstraZeneca Plc, Pfizer Inc., Biogen Inc., and
Amgen Inc.
Key questions addressed by the report
·
What is the market growth rate?
·
Which segment dominates the market in the base
year?
·
Which segment will project the fastest growth in
the market?
·
How COVID-19 impacted the market?
·
Recovery Timeline
·
Deviation from the pre-COVID-19 forecast
·
Most affected segment
·
Who is the leader in the market?
·
How players are addressing challenges to sustain
growth?
·
Where is the investment opportunity?
(Get 15% Discount on Buying this Report)
A full
Report of North American Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/north-american-neurological-disorder-drugs-market
North America Neurological Disorder Drugs Market –
Segmentation
By Disorder Type
·
Alzheimer’s Disease
·
Parkinson’s Disease
·
Multiple Sclerosis
·
Huntington Disease
·
Others
North America Neurological Disorder Drugs Market –
Countries Covered
·
US
·
Canada
Company Profiles
·
AbbVie Inc.
·
Overview
·
Abbvie Inc. in North America
·
Abbvies Inc. in Neurological Disorder Drugs
Landscape
·
Recent Developments
·
ACADIA Pharmaceuticals Inc.
·
ApotexInc.
·
Allergan Plc
·
Amgen Inc.
·
AstraZeneca Plc
·
Biogen Inc.
·
Boehringer Ingelheim International GmbH
·
Eli Lilly and Co.
·
F. Hoffmann-La Roche Ltd.
·
Merck & Co. Inc.
·
Novartis AG
·
Pfizer Inc.
Reasons
to buy from us –
1.
We cover more than 15 major industries, further segmented into more than 90
sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-neurological-disorder-drugs-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion
Market Research
Contact Person: Mr.
Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment